Target intelligence / Profile preview

NXT1 antisense RNA 1 (NXT1-AS1)

Target: NXT1-AS1
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA

Overview

NXT1 antisense RNA 1 is a long non-coding RNA transcribed in the antisense orientation relative to the NXT1 gene[7]. Long non-coding antisense RNAs like NXT1-AS1 frequently regulate the expression, stability, or processing of their sense gene partners, but the specific biological functions of NXT1-AS1 remain uncharacterized in the current literature. There is no evidence it encodes a protein, nor is it currently recognized as a disease biomarker, therapeutic target, or agent of pharmacological interest[7][1][2].

Mechanism of action

None known.

Biological functions

Regulation of gene expression (transcription, RNA stability, or RNA processing) - by analogy with other antisense RNAs, specific function for NXT1-AS1 uncharacterized

Beyond the preview

Go deeper on NXT1 antisense RNA 1 (NXT1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NXT1 antisense RNA 1 (NXT1-AS1).

Explore the full profile